COVID-19 Vaccines: Ocugen’s EUA Request For Covaxin In Kids Faces Steep Climb At US FDA

 
• By Sue Sutter
  
Rock climber
Convincing the US FDA that data support an EUA for pediatric use of Covaxin could be a multi-pitch effort for Ocugen. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet